News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
China BioPharma Ltd. Appoints Dr. Yimin Yu, Current Chairman Of HYTE Research To Advisory Board
April 20, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ISELIN, N.J.--(BUSINESS WIRE)--April 20, 2006--Techedge Inc. (OTCBB:TEDG - News) announced that China BioPharma, Ltd. has appointed Dr. Yimin Yu, the current Chairman of HYTE Research, LLC to the company's Board of Advisors.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Mergers & acquisitions
UPDATE: Pfizer Files Lawsuits Against Novo Nordisk, Metsera To Stop Rival Bid
November 3, 2025
·
3 min read
·
Tristan Manalac
FDA
FDA’s Tidmarsh Exits Amid ‘Personal Conduct’ Probe
November 3, 2025
·
2 min read
·
Tristan Manalac
Editorial
Novo’s CEO Doesn’t Seem To Mind Being Big Pharma’s Villian
October 31, 2025
·
3 min read
·
Annalee Armstrong
Earnings
AbbVie’s Immunology Dyad Dominates Again in Q3
October 31, 2025
·
2 min read
·
Dan Samorodnitsky